Compare MYE & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MYE | ESPR |
|---|---|---|
| Founded | 1933 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 674.8M | 660.1M |
| IPO Year | N/A | 2013 |
| Metric | MYE | ESPR |
|---|---|---|
| Price | $18.45 | $3.70 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 7 |
| Target Price | ★ $21.00 | $6.86 |
| AVG Volume (30 Days) | 205.5K | ★ 7.0M |
| Earning Date | 10-30-2025 | 11-06-2025 |
| Dividend Yield | ★ 2.94% | N/A |
| EPS Growth | ★ 77.06 | N/A |
| EPS | ★ 0.74 | N/A |
| Revenue | ★ $825,644,000.00 | $303,802,000.00 |
| Revenue This Year | N/A | $25.45 |
| Revenue Next Year | $0.98 | N/A |
| P/E Ratio | $24.90 | ★ N/A |
| Revenue Growth | 0.26 | ★ 2.83 |
| 52 Week Low | $9.06 | $0.69 |
| 52 Week High | $18.61 | $4.03 |
| Indicator | MYE | ESPR |
|---|---|---|
| Relative Strength Index (RSI) | 65.55 | 63.61 |
| Support Level | $17.94 | $3.59 |
| Resistance Level | $18.29 | $3.91 |
| Average True Range (ATR) | 0.39 | 0.24 |
| MACD | 0.07 | 0.05 |
| Stochastic Oscillator | 87.72 | 77.74 |
Myers Industries Inc designs, manufactures, and markets a variety of plastic, metal, and rubber products, including a broad selection of plastic reusable containers, pallets, small parts bins, bulk shipping containers, storage and organization products, OEM parts, custom plastic products, consumer fuel containers and tanks for water, fuel and waste handling. It operates through the following segments: The Material Handling segment manufactures a selection of durable plastic reusable products that are used repeatedly during the course of their service life. The Distribution segment is engaged in the distribution of equipment, tools, and supplies used for tire servicing and automotive under-vehicle repair, etc. It generates the majority of its revenue from the Material Handling segment.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.